Gemigliptin: Newer promising gliptin for type 2 diabetes mellitus
The dipeptidyl peptidase-4 (DPP-4) inhibitors have facilitated the management of type 2 diabetes mellitus (T2DM) owing to their superior efficacy and safety with low incidence of adverse effects. Gemigliptin is a new member of this family of drugs, and studies have revealed certain advantages of gem...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Wolters Kluwer Medknow Publications
2017-01-01
|
| Sraith: | Indian Journal of Endocrinology and Metabolism |
| Ábhair: | |
| Rochtain ar líne: | http://www.ijem.in/article.asp?issn=2230-8210;year=2017;volume=21;issue=6;spage=898;epage=902;aulast=Gutch |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|